4//SEC Filing
Seghezzi Graziano 4
Accession 0001179110-13-006693
CIK 0001477598other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:09 PM ET
Size
9.0 KB
Accession
0001179110-13-006693
Insider Transaction Report
Form 4
Seghezzi Graziano
Director
Transactions
- Award
Secured Convertible Promissory Note
2013-04-11+0→ 0 total(indirect: See footnote)Exercise: $8.00From: 2013-04-16Exp: 2014-02-15→ Common Stock (0 underlying) - Award
Warrant (right to buy)
2013-04-11+0→ 0 total(indirect: See footnote)Exercise: $0.01From: 2013-04-16Exp: 2023-02-15→ Common Stock (0 underlying)
Footnotes (5)
- [F1]Upon the closing of the Issuer's initial public offering ("IPO"), Sofinnova Capital VI FCPR ("Sofinnova") will directly hold 156,250 shares of Common Stock less the number of shares equal to the payment of the exercise price upon conversion of the warrant.
- [F2]The warrant and the Secured Convertible Promissory Note are held directly by Sofinnova. The reporting person is a partner of Sofinnova Partners SAS, which is the managing company of Sofinnova. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]Upon the closing of the Issuer's IPO, Sofinnova will directly hold 633,219 shares of Common Stock upon conversion of the Secured Convertible Promissory Note.
- [F4]This is the maturity date of the Secured Convertible Promissory Note.
- [F5]The Secured Convertible Promissory Note was issued to Sofinnova in exchange for $5,000,000.
Documents
Issuer
Omthera Pharmaceuticals, Inc.
CIK 0001477598
Entity typeother
Related Parties
1- filerCIK 0001573749
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:09 PM ET
- Size
- 9.0 KB